PortfoliosLab logoPortfoliosLab logo
IMMX vs. VMNIX
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

IMMX vs. VMNIX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Immix Biopharma, Inc. (IMMX) and Vanguard Market Neutral Fund Institutional Shares (VMNIX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, IMMX achieves a 61.38% return, which is significantly higher than VMNIX's 12.09% return.


IMMX

1D
0.90%
1M
-10.97%
YTD
61.38%
6M
103.37%
1Y
300.00%
3Y*
60.54%
5Y*
10Y*

VMNIX

1D
0.45%
1M
0.84%
YTD
12.09%
6M
13.72%
1Y
18.13%
3Y*
13.30%
5Y*
12.99%
10Y*
5.07%
*Multi-year figures are annualized to reflect compound growth (CAGR)

IMMX vs. VMNIX - Yearly Performance Comparison


2026 (YTD)20252024202320222021
IMMX
Immix Biopharma, Inc.
61.38%137.73%-68.21%202.18%-35.67%-3.00%
VMNIX
Vanguard Market Neutral Fund Institutional Shares
12.09%9.36%5.84%12.33%13.47%1.78%

Correlation

The correlation between IMMX and VMNIX is -0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.06

Correlation (3Y)
Calculated over the trailing 3-year period

0.00

Correlation (All Time)
Calculated using the full available price history since Dec 17, 2021

0.00

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IMMX vs. VMNIX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IMMX
IMMX Risk / Return Rank: 9393
Overall Rank
IMMX Sharpe Ratio Rank: 9696
Sharpe Ratio Rank
IMMX Sortino Ratio Rank: 9292
Sortino Ratio Rank
IMMX Omega Ratio Rank: 8989
Omega Ratio Rank
IMMX Calmar Ratio Rank: 9595
Calmar Ratio Rank
IMMX Martin Ratio Rank: 9393
Martin Ratio Rank

VMNIX
VMNIX Risk / Return Rank: 6363
Overall Rank
VMNIX Sharpe Ratio Rank: 5959
Sharpe Ratio Rank
VMNIX Sortino Ratio Rank: 6767
Sortino Ratio Rank
VMNIX Omega Ratio Rank: 5555
Omega Ratio Rank
VMNIX Calmar Ratio Rank: 8282
Calmar Ratio Rank
VMNIX Martin Ratio Rank: 5151
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IMMX vs. VMNIX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Immix Biopharma, Inc. (IMMX) and Vanguard Market Neutral Fund Institutional Shares (VMNIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


IMMXVMNIXDifference

Sharpe ratio

Return per unit of total volatility

3.58

2.26

+1.32

Sortino ratio

Return per unit of downside risk

3.56

3.40

+0.16

Omega ratio

Gain probability vs. loss probability

1.41

1.41

0.00

Calmar ratio

Return relative to maximum drawdown

7.59

3.77

+3.82

Martin ratio

Return relative to average drawdown

16.73

10.50

+6.22

IMMX vs. VMNIX - Sharpe Ratio Comparison

The current IMMX Sharpe Ratio is 3.58, which is higher than the VMNIX Sharpe Ratio of 2.26. The chart below compares the historical Sharpe Ratios of IMMX and VMNIX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


IMMXVMNIXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

3.58

2.26

+1.32

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

1.81

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.79

Sharpe Ratio (All Time)

Calculated using the full available price history

0.19

0.34

-0.15

Drawdowns

IMMX vs. VMNIX - Drawdown Comparison

The maximum IMMX drawdown since its inception was -88.89%, which is greater than VMNIX's maximum drawdown of -27.90%. Use the drawdown chart below to compare losses from any high point for IMMX and VMNIX.


Loading charts...

Drawdown Indicators


IMMXVMNIXDifference

Max Drawdown

Largest peak-to-trough decline

-88.89%

-27.90%

-60.99%

Max Drawdown (1Y)

Largest decline over 1 year

-39.84%

-4.67%

-35.17%

Max Drawdown (3Y)

Largest decline over 3 years

-81.57%

-5.36%

-76.21%

Max Drawdown (5Y)

Largest decline over 5 years

-6.69%

Max Drawdown (10Y)

Largest decline over 10 years

-24.95%

Current Drawdown

Current decline from peak

-24.10%

0.00%

-24.10%

Average Drawdown

Average peak-to-trough decline

-58.71%

-8.76%

-49.95%

Ulcer Index

Depth and duration of drawdowns from previous peaks

18.03%

1.74%

+16.29%

Volatility

IMMX vs. VMNIX - Volatility Comparison

Immix Biopharma, Inc. (IMMX) has a higher volatility of 20.91% compared to Vanguard Market Neutral Fund Institutional Shares (VMNIX) at 2.02%. This indicates that IMMX's price experiences larger fluctuations and is considered to be riskier than VMNIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


IMMXVMNIXDifference

Volatility (1M)

Calculated over the trailing 1-month period

20.91%

2.02%

+18.89%

Volatility (6M)

Calculated over the trailing 6-month period

60.52%

5.75%

+54.77%

Volatility (1Y)

Calculated over the trailing 1-year period

86.61%

7.81%

+78.80%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

109.41%

7.22%

+102.19%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

109.41%

6.41%

+103.00%

Dividends

IMMX vs. VMNIX - Dividend Comparison

IMMX has not paid dividends to shareholders, while VMNIX's dividend yield for the trailing twelve months is around 3.19%.


PositionTTM20252024202320222021202020192018201720162015
IMMX
Immix Biopharma, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
VMNIX
Vanguard Market Neutral Fund Institutional Shares
3.19%3.59%5.67%5.15%0.78%0.20%0.86%3.23%1.00%1.16%0.45%0.10%

Frequently Asked Questions


IMMX and VMNIX have a correlation of -0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IMMX has higher volatility (20.91%) compared to VMNIX (2.02%). In terms of maximum drawdown, IMMX dropped -88.89% vs VMNIX's -27.90%.

IMMX currently has the higher Sharpe Ratio (3.58 vs 2.26), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for IMMX and VMNIX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer